JP2021503468A5 - - Google Patents

Info

Publication number

JP2021503468A5

JP2021503468A5 JP2020527008A JP2020527008A JP2021503468A5 JP 2021503468 A5 JP2021503468 A5 JP 2021503468A5 JP 2020527008 A JP2020527008 A JP 2020527008A JP 2020527008 A JP2020527008 A JP 2020527008A JP 2021503468 A5 JP2021503468 A5 JP 2021503468A5

Authority

JP

Japan

Prior art keywords

composition

cage

geranate

choline

active compound

Prior art date

2018-11-16

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 239000000203 mixture Substances 0.000 claims description 95
• 238000000034 method Methods 0.000 claims description 82
• 150000001875 compounds Chemical class 0.000 claims description 81
• ZHYZQXUYZJNEHD-VQHVLOKHSA-M geranate Chemical compound CC(C)=CCC\C(C)=C\C([O-])=O ZHYZQXUYZJNEHD-VQHVLOKHSA-M 0.000 claims description 55
• OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 47
• 229960001231 choline Drugs 0.000 claims description 47
• ZHYZQXUYZJNEHD-VQHVLOKHSA-N geranic acid Chemical compound CC(C)=CCC\C(C)=C\C(O)=O ZHYZQXUYZJNEHD-VQHVLOKHSA-N 0.000 claims description 42
• 229930008392 geranic acid Natural products 0.000 claims description 42
• ZHYZQXUYZJNEHD-UHFFFAOYSA-N trans-geranic acid Natural products CC(C)=CCCC(C)=CC(O)=O ZHYZQXUYZJNEHD-UHFFFAOYSA-N 0.000 claims description 42
• 239000002608 ionic liquid Substances 0.000 claims description 30
• 150000003839 salts Chemical class 0.000 claims description 23
• 102000039446 nucleic acids Human genes 0.000 claims description 18
• 108020004707 nucleic acids Proteins 0.000 claims description 18
• 150000007523 nucleic acids Chemical class 0.000 claims description 18
• 150000001450 anions Chemical class 0.000 claims description 15
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 12
• 210000004877 mucosa Anatomy 0.000 claims description 12
• 201000010099 disease Diseases 0.000 claims description 11
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 11
• 206010028980 Neoplasm Diseases 0.000 claims description 9
• 208000008589 Obesity Diseases 0.000 claims description 9
• 239000003153 chemical reaction reagent Substances 0.000 claims description 9
• 235000020824 obesity Nutrition 0.000 claims description 9
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 9
• 150000003384 small molecules Chemical class 0.000 claims description 9
• 229920001184 polypeptide Polymers 0.000 claims description 7
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 7
• 210000001519 tissue Anatomy 0.000 claims description 7
• 102400000322 Glucagon-like peptide 1 Human genes 0.000 claims description 6
• 102000004877 Insulin Human genes 0.000 claims description 6
• 108090001061 Insulin Proteins 0.000 claims description 6
• 230000000973 chemotherapeutic effect Effects 0.000 claims description 6
• 229940125396 insulin Drugs 0.000 claims description 6
• 201000011510 cancer Diseases 0.000 claims description 5
• 230000003278 mimic effect Effects 0.000 claims description 5
• 210000002200 mouth mucosa Anatomy 0.000 claims description 5
• 210000002850 nasal mucosa Anatomy 0.000 claims description 5
• 230000001225 therapeutic effect Effects 0.000 claims description 5
• 238000002347 injection Methods 0.000 claims description 4
• 239000007924 injection Substances 0.000 claims description 4
• 238000007920 subcutaneous administration Methods 0.000 claims description 4
• 206010016654 Fibrosis Diseases 0.000 claims description 3
• 208000025865 Ulcer Diseases 0.000 claims description 3
• 239000013543 active substance Substances 0.000 claims description 3
• 150000001768 cations Chemical class 0.000 claims description 3
• 206010012601 diabetes mellitus Diseases 0.000 claims description 3
• 230000004761 fibrosis Effects 0.000 claims description 3
• 206010020718 hyperplasia Diseases 0.000 claims description 3
• 230000035755 proliferation Effects 0.000 claims description 3
• 231100000397 ulcer Toxicity 0.000 claims description 3
• 230000004584 weight gain Effects 0.000 claims description 3
• 235000019786 weight gain Nutrition 0.000 claims description 3
• 230000037396 body weight Effects 0.000 claims description 2
• 239000003937 drug carrier Substances 0.000 claims description 2
• 239000013604 expression vector Substances 0.000 claims description 2
• 230000002401 inhibitory effect Effects 0.000 claims description 2
• 238000001990 intravenous administration Methods 0.000 claims description 2
• 230000002265 prevention Effects 0.000 claims description 2
• 239000013598 vector Substances 0.000 claims description 2
• 229920002148 Gellan gum Polymers 0.000 claims 2
• 239000002253 acid Substances 0.000 claims 2
• 238000000338 in vitro Methods 0.000 claims 2
• 210000004400 mucous membrane Anatomy 0.000 claims 2
• 239000003814 drug Substances 0.000 claims 1
• 239000002105 nanoparticle Substances 0.000 description 6
• 239000007788 liquid Substances 0.000 description 4
• 239000000243 solution Substances 0.000 description 3
• 239000000725 suspension Substances 0.000 description 3
• 239000007864 aqueous solution Substances 0.000 description 2
• HJJPJSXJAXAIPN-UHFFFAOYSA-N arecoline Chemical compound COC(=O)C1=CCCN(C)C1 HJJPJSXJAXAIPN-UHFFFAOYSA-N 0.000 description 2
• 230000004071 biological effect Effects 0.000 description 2
• 239000000470 constituent Substances 0.000 description 2
• 230000000694 effects Effects 0.000 description 2
• 229940126062 Compound A Drugs 0.000 description 1
• NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
• 239000002775 capsule Substances 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• 238000007911 parenteral administration Methods 0.000 description 1
• 230000004580 weight loss Effects 0.000 description 1